浙江仙琚制药股份有限公司关于醋酸地塞米松片通过一致性评价的公告

Group 1 - The company has received approval from the National Medical Products Administration for the acetyl dexamethasone tablets, which have passed the consistency evaluation of quality and efficacy for generic drugs [1][2] - The approved specification for the acetyl dexamethasone tablets is 0.75mg, with the drug approval number being H33020822 [2] - Acetyl dexamethasone tablets are corticosteroids primarily used for allergic and autoimmune inflammatory diseases, including connective tissue diseases, severe bronchial asthma, dermatitis, ulcerative colitis, acute leukemia, and malignant lymphoma [1][2] Group 2 - The approval of acetyl dexamethasone tablets is expected to strengthen and enhance the product's market competitiveness, providing valuable experience for the company's future consistency evaluation work [2]